Key result
Rural residence linked to ~3-fold higher malignancy risk after acute coronary syndrome over long-term follow-up.
Why the study?
Increased cancer risk has been reported in patients with acute coronary syndrome, but geographic differences in malignancy risk long after ACS were unclear.
Does living in a rural area compared to an urban area increase the risk of malignancy in patients with acute coronary syndrome?
Cohort (n=586)
Yes
Does living in a rural area compared to an urban area increase the risk of malignancy in patients with acute coronary syndrome?
In patients with acute coronary syndrome, living in rural areas was associated with a significantly higher risk of developing malignancy over a 22-year follow-up compared to urban areas.
Answers are grounded in this paper and cite their sources.
Geographic disparities in post-ACS malignancy risk may warrant tailored surveillance; leaves open whether urban-rural factors are causal or confounded.
BACKGROUND: Increased cancer risk has been reported in patients with acute coronary syndrome (ACS). OBJECTIVES: To investigate geographic differences in risk malignancy long after ACS. METHODS: We enrolled 586 ACS patients admitted to hospitals in three provinces in the Veneto region of Italy in this prospective study. Patient's residency was classified into three urban and three nearby rural areas. RESULTS: All (except for 3) patients completed the follow-up (22 years or death) and 54 % were living in rural areas. Sixteen patients had pre-existing malignancy, and 106 developed the disease during follow-up. Cancer prevalence was 17 % and 24 % (p = 0.05) and incidence of malignancy was 16 and 21/1000 person-years for urban and rural areas, respectively. In unadjusted logistic regression analysis, cancer risk increased from urban to rural areas (odds ratio [OR] 3.4;95 % confidence interval [CI] 1.7-7.1; p = 0.001), with little change from north to south provinces (OR 1.5;95 % CI 1.0-2.2; p = 0.06). Yet, we found a strong positive interaction between urban-rural areas and provinces (OR 2.1;95 % CI 1.2-3.5; p = 0.003). These results kept true in the fully adjusted model. Unadjusted Cox regression analysis revealed increasing hazards ratios (HRs) for malignancy onset from urban to rural areas (HR 3.0;95 % CI 1.5-6.2; p = 0.02), but not among provinces (HR 1.3;95 % CI 1.0-2.0; p = 0.14). Also, we found a strong positive interaction between geographic areas (HR 2.1;95 % CI 1.3-3.5; p = 0.002), even with a fully adjusted model. CONCLUSIONS: The results in unselected real-world patients demonstrate a significant geographic difference in malignancy risk in ACS patients, with the highest risk in the north-rural area.
No takes yet. Share an insight, caveat, or question.
Berton et al. (2021) conducted a cohort in Acute coronary syndrome (n=586). Rural residency vs. Urban residency was evaluated on Malignancy onset (HR 3.2, 95% CI 1.6-6.6, p=0.001). Living in a rural area was associated with a significantly higher risk of malignancy onset compared to living in an urban area among patients with acute coronary syndrome over a 22-year follow-up (adjusted HR 3.2).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: